IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Apr 2006 (Vol: 2006, Issue: 70)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
The Impact of Clinical Risk Published: 1 Apr-2006
By: Fintan Walton
Abstract Fulltext:
Section: Cartoons
Labelling Published: 6 Apr-2006
Details
Section: Deal Trackers
Surfaxin (lucinactant) Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Celliance and Novo Nordisk Extend Insulin Distribution Alliance Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: Features
Novartis Signs Cancer Deal with Infinite Promise Published: 1 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Myogen's Unpopular Ambrisentan Deal with GSK Published: 1 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Spotlight on Influenza - Separating Fact from Fiction in the Fight against Influenza Published: 1 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Tuberculosis Published: 1 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: General
NicOx Upgrades Preclinical Deals Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Avidex Ltd Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Hana Biosciences Licenses Cancer Products from Inex Pharmaceuticals Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Watson to Acquire Andrx for US$1.9 B Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Neuromed Pharmaceuticals and Merck Collaborate for Novel Pain Drugs Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:
Exelixis’ and Sankyo’s Cardiovascular Collaboration Published: 6 Apr-2006
By: Business Review Editor
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.